{"id":45855,"date":"2022-07-06T14:01:55","date_gmt":"2022-07-06T12:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/"},"modified":"2022-07-06T14:01:55","modified_gmt":"2022-07-06T12:01:55","slug":"caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/","title":{"rendered":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics<\/a> today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent advances in the Company\u2019s lead program targeting the lysosomal cation channel, TRPML1, for the treatment of GBA-Parkinson\u2019s disease (GBA-PD) and other rare genetic diseases.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe have demonstrated that enhancing TRPML1 function boosts lysosomal function, enhances key lipid recycling pathways that are compromised in GBA-PD patients, and speeds up the clearance of toxic materials that accumulate in a number of genetically defined diseases,\u201d said Williams. \u201cI look forward to speaking with Myles about updates to our TRPML1 program, as well as engaging with investors at the William Blair conference.\u201d\n<\/p>\n

\nAbout Caraway Therapeutics<\/b>\n<\/p>\n

\nCaraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The Company is a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components by modulating lysosomal function. Caraway is utilizing its unique product engine to develop proprietary insights into lysosomal function and small molecule ion channel modulation and advance a robust pipeline of precision therapeutic candidates with disease-modifying potential for patients. The Company is backed by top-tier investors, including SV Health Investors, AbbVie Ventures, MRLV Fund, Amgen Ventures, Dementia Discovery Fund, Alexandria Venture Investments, and Eisai Innovation.\n<\/p>\n

\nCaraway is based in Cambridge, MA. For more information, please visit www.carawaytx.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
MacDougall
\n
Kari Watson or Nicholas Chang
\n
(781) 235-3060
\n
kwatson@macdougall.bio<\/a> or nchang@macdougall.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45855","6":"format-standard","7":"category-industry"},"yoast_head":"\nCaraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-06T12:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference\",\"datePublished\":\"2022-07-06T12:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/\"},\"wordCount\":296,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005067\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/\",\"name\":\"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005067\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"datePublished\":\"2022-07-06T12:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005067\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005067\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/","og_locale":"en_US","og_type":"article","og_title":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-06T12:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference","datePublished":"2022-07-06T12:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/"},"wordCount":296,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/","url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/","name":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg","datePublished":"2022-07-06T12:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220706005067\/en\/837856\/21\/CarawayTx_rgb_large.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-participate-in-william-blair-biotech-focus-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Caraway Therapeutics to Participate in William Blair Biotech Focus Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45855"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45855\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}